Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Cited by (1,000)

Items 701–800 of 1,000

1. IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling
   Hai-Yu Xiong, Tingting Ma, Bitao Wu, Yan Lin, Zhiguang Tu · 2014 · Asian Pacific Journal of Cancer Prevention
2. The 100 top-cited studies in cancer immunotherapy
   Yonggang Zhang, Liuliu Quan, Liang Du · 2019 · Artificial Cells Nanomedicine and Biotechnology
3. Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside
   Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat et al. · 2022 · Life Sciences
4. Adoptive T cell therapy of solid cancers
   Keith L. Knutson, Wolfgang Wagner, Mary Lenora Disis · 2005 · Cancer Immunology Immunotherapy
5. The impact of the TIM gene family on tumor immunity and immunosuppression
   Muhammad Baghdadi, Masahisa Jinushi · 2013 · Cellular and Molecular Immunology
6. Mechanisms regulating immune surveillance of cellular stress in cancer
   Ruth Seelige, Stephen C. Searles, Jack D. Bui · 2017 · Cellular and Molecular Life Sciences
7. Dendritic Cells in Cancer
   Russell D. Salter, Michael R. Shurin · 2009 · Springer eBooks
8. Colorectal cancer vaccines: Principles, results, and perspectives
   Simone Mocellin M. D, Carlo Riccardo Rossi, Mario Lise, Donato Nitti · 2004 · Gastroenterology
9. Gene therapy for ovarian cancer
   Kristopher J. Kimball, T. Michael Numnum, Rodney Paul Rocconi, Ronald David Alvarez · 2006 · Current Oncology Reports
10. Biodegradable Polymer Microparticles with Tunable Shapes and Surface Textures for Enhancement of Dendritic Cell Maturation
    Mubashir Hussain, Jun Xie, Ke Wang, Hua Wang, Zhengping Tan, Qianqian Liu, Zhen Geng, Khurram Shezad, Laila Noureen, Hao Jiang et al. · 2019 · ACS Applied Materials & Interfaces
11. Monocyte-Derived Cells in Tissue-Resident Memory T Cell Formation
    Kuan-Lun Chu, Nathália Vieira Batista, Mélanie Girard, Tania H. Watts · 2020 · The Journal of Immunology
12. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)
    Federica Raggi, Maria Carla Bosco · 2020 · Cancers
13. High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy
    Dagmar Riemann, Wolfgang Schütte, Steffi Turzer, Barbara Seliger, Miriam Möller · 2020 · Cancers
14. Immune evasive mechanisms contributing to persistent Leishmania donovani infection
    Simona Stäger, Trupti Joshi, Rashmi Bankoti · 2010 · Immunologic Research
15. B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction
    Ling Chen, Takeshi Azuma, Weiwei Yu, Zheng Xu, Liqun Luo, Lieping Chen · 2018 · Proceedings of the National Academy of Sciences
16. Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology
    Dan A. Laheru, Drew M. Pardoll, Elizabeth M. Jaffee · 2005 · Molecular Cancer Therapeutics
17. Emerging Monoclonal Antibodies and Related Agents for the Treatment of Chronic Lymphocytic Leukemia
    Tadeusz Robak · 2012 · Future Oncology
18. Correlation between tumor microenvironment‑associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer
    Siyu Zhang, Wenqi Bai, Xunan Tong, Peng Bu, Jing Xu, Yanfeng Xi · 2018 · Oncology Letters
19. Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
    Nannan Liu, Xinxiu Jiang, Leiming Guo, Chuchu Zhang, Meimei Jiang, Zhuoran Sun, Yizheng Zhang, Wunan Mi, Jiehan Li, Yang Fu et al. · 2022 · International Journal of Biological Sciences
20. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non‐Hodgkin lymphoma
    Naveen K. Dakappagari, Steffan N. Ho, Randy D. Gascoyne, Julie Ranuio, Andrew P. Weng, Shabnam Tangri · 2011 · Cytometry Part B Clinical Cytometry
21. Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma
    Yunhong Xia, Rongxin Chen, Sheng‐Long Ye, Ruixia Sun, Jun Chen, Yan Zhao · 2011 · Clinical & Experimental Metastasis
22. Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer.
    Tomoyuki Matsunaga, Hiroaki Saito, Masahide Ikeguchi · 2011 · Europe PMC (PubMed Central)
23. Immune regulation in the tumor microenvironment and its relevance in cancer therapy
    Weiping Zou · 2021 · Cellular and Molecular Immunology
24. Cancer Immunotherapy
    Fumito Ito, Alfred E. Chang · 2013 · Surgical Oncology Clinics of North America
25. Cellular immunotherapy for ovarian cancer
    Martin J. Cannon, Timothy J. O’Brien · 2009 · Expert Opinion on Biological Therapy
26. Nivolumab in melanoma
    Pol M. Specenier · 2016 · Expert Review of Anticancer Therapy
27. Tolerogenic Transcriptional Signatures of Steady-State and Pathogen-Induced Dendritic Cells
    Emilia Vendelova, DiyaaElDin Ashour, Patrick Blank, Florian Erhard, Antoine‐Emmanuel Saliba, Ulrich Kalinke, Manfred Bernhard Lutz · 2018 · Frontiers in Immunology
28. Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
    Xiaofeng Liu, Chunguang Shan, Yingluan Song, Juan Du · 2019 · Frontiers in Oncology
29. Impact of inflammation and immunotherapy in renal cell carcinoma (Review)
    Jian Shi, Keshan Wang, Zhiyong Xiong, Changfei Yuan, Cheng Wang, Qi Cao, Yu Huang, Xiangui Meng, Kairu Xie, Zhixian Cheng et al. · 2020 · Oncology Letters
30. Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer
    Ana M. Vuletić, Katarina Mirjačić Martinović, Nevena Tišma Miletić, Jérôme Zoidakis, Sergi Castellvı́-Bel, Milena R. Cavic · 2021 · Frontiers in Cell and Developmental Biology
31. Regulatory T Cells: A New Frontier in Cancer Immunotherapy
    Brian G. Barnett, Jens Rüter, Ilona Kryczek, Michael J. Brumlik, Pui Joan Cheng, Benjamin J. Daniel, George Coukos, Weiping Zou, Tyler Jay Curiel · 2008 · Springer eBooks
32. T Cells and Costimulation in Cancer
    Tomasz Maj, Shuang Wei, Ted Welling, Weiping Zou · 2013 · The Cancer Journal
33. Immune Response Activation
    Guy Huynh Thien Duc · 2014 · InTech eBooks
34. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis
    Lingchuan Guo, Zhiju Liu, Yun Zhang, Qiuying Quan, Lili Huang, Yunyun Xu, Lei Cao, Xueguang Zhang · 2019 · Medicine
35. Coinhibitory molecules in cancer biology and therapy
    Simone Mocellin M. D, Clara Benna, Pierluigi Pilati · 2013 · Cytokine & Growth Factor Reviews
36. Immunotherapy for head and neck squamous cell carcinoma
    Qiao Li, Mark E. Prince, Jeffrey S. Moyer · 2015 · Oral Oncology
37. Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
    Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu et al. · 2020 · Cancer Biology and Medicine
38. A vasculature-centric approach to developing novel treatment options for glioblastoma
    Hans‐Georg Wirsching, Patrick Roth, Michael Weller · 2021 · Expert Opinion on Therapeutic Targets
39. miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells
    Wei‐An Chang, Ming‐Ju Tsai, Jen‐Yu Hung, Kuan‐Li Wu, Ying‐Ming Tsai, Yung‐Chi Huang, Chao‐Yuan Chang, Pei-Hsun Tsai, Ya‐Ling Hsu · 2021 · Cancers
40. OVEREXPRESSION OF B7-H4 IN TUMOR INFILTRATED DENDRITIC CELLS
    Chen Cheng, Qiu‐Xia Qu, Yu Shen, Yantian Lv, Yibei Zhu, Xueguang Zhang, Jian‐An Huang · 2011 · Journal of Immunoassay and Immunochemistry
41. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells
    Qing Ding, Liming Lu, Xiaorong Zhou, Yun Zhou, Kuang-Yen Chou · 2011 · Journal of Leukocyte Biology
42. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro
    Xia Yang, Feng Qian, Haiyang He, Kaijun Liu, Yuanzhi Lan, Bing Ni, Yi Tian, Xiaolan Fu, Ji Zhang, Zigang Shen et al. · 2011 · Brazilian Journal of Medical and Biological Research
43. Prognostic significance of programmed cell death‐1‐positive cells in follicular lymphoma patients may alter in the rituximab era
    Hiroyuki Takahashi, Naoto Tomita, Seiji Sakata, Naoko Tsuyama, Chizuko Hashimoto, Rika Ohshima, Shiro Matsuura, Koji Ogawa, Wataru Yamamoto, Yoichi Kameda et al. · 2013 · European Journal Of Haematology
44. New targeted treatments for non-small-cell lung cancer – role of nivolumab
    Paul Baas, Mirte Muller, Michel M. van den Heuvel, Giulia Zago · 2016 · Biologics
45. Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models
    Yohei Takeda, Sumito Yoshida, Ken Takashima, Noriko Ishii‐Mugikura, Hiroaki Shime, Tsukasa Seya, Misako Matsumoto · 2018 · Cancer Science
46. Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells
    Jenny Lazarus, Morgan D. Oneka, Souptik Barua, Tomasz Maj, Mirna Perusina Lanfranca, Lawrence Delrosario, Lei Sun, Jesse Joshua Smith, Michael Ian D'Angelica, Jinru Shia et al. · 2019 · Annals of Surgical Oncology
47. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches
    Ali Hazrati, Kosar Malekpour, Zahra Mirsanei, Arezou Khosrojerdi, Nasim Rahmani-Kukia, Neda Heidari, Ardeshir Abbasi, Sara Soudi · 2023 · Frontiers in Immunology
48. Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
    Lingrong Hu, Chengliang Sun, Kai Yuan, Peng Yang · 2024 · Drug Discovery Today
49. Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells
    Wu Li, Zhen Chen, Jian Zhang, Yiqiao Xing · 2012 · Journal of Huazhong University of Science and Technology [Medical Sciences]
50. Anti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potential
    Morganna Freeman-Keller, Jeffrey S. Weber · 2014 · Therapeutic Advances in Medical Oncology
51. Differentiation and activation of equine monocyte‐derived dendritic cells are not correlated with CD 206 or CD 83 expression
    Nathifa A. Moyo, Emanuele Marchi, Falko Steinbach · 2013 · Immunology
52. Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
    Gemma Louise Owens, Marcus J. Price, Eleanor J. Cheadle, Robert E. Hawkins, David Edward Gilham, Richard John Edmondson · 2018 · Cancer Immunology Immunotherapy
53. The Importance of Human Tissue Bioresources in Advancing Biomedical Research
    Sameer Al Diffalha, Katherine C. Sexton, Peter Hamilton Watson, William E. Grizzle · 2019 · Biopreservation and Biobanking
54. An effective cell-penetrating antibody delivery platform
    Andreas Herrmann, Toshikage Nagao, Chunyan Zhang, Christoph Lahtz, Yijia Li, Chanyu Yue, Ronja Isabelle Mülfarth, Hua Yu · 2019 · JCI Insight
55. β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Gennaro Bruno, Nicoletta Nastasi, Angela Subbiani, Alessia Boaretto, Sara Ciullini Mannurita, Gianluca Mattei, Patrizia Nardini, Chiara Della Bella, Alberto Magi, Alessandro Pini et al. · 2023 · Cancer Gene Therapy
56. Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition
    Achinto Saha, Shengyuan Zhao, Austin Kindall, Carly S. Wilder, Chelsea A. Friedman, Rachel Clark, George Georgiou, Everett M Stone, Dawit Kidane, John DiGiovanni · 2023 · Journal of Experimental & Clinical Cancer Research
57. Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul
    Greg M. Delgoffe · 2016 · Cancer Immunology Research
58. Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer
    Chang-Suk Chae, Elí Terán-Cabanillas, Juan R. Cubillos‐Ruiz · 2017 · Cancer Immunology Immunotherapy
59. Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer
    Wenkun Bai, Wei jin Zhang, Bing Hu · 2018 · OncoTargets and Therapy
60. Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Min Zhang, Kehai Liu, Mingfu Wang · 2019 · RSC Advances
61. Increased Regulatory versus Effector T Cell Development Is Associated with Thymus Atrophy in Mouse Models of Multiple Myeloma
    Ayelet Laronne, Dov Zipori, Nechama Haran‐Ghera · 2008 · The Journal of Immunology
62. N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1
    Bar Kaufman, Muhammad Abu-Ahmad, Olga Radinsky, Eman Gharra, Tal Manko, Baisali Bhattacharya, Daniela Gologan, Nofar Erlichman, Tsipi Meshel, Yoav Nuta et al. · 2025 · Molecular Cancer
63. Unravelling T cell exhaustion through co‐inhibitory receptors and its transformative role in cancer immunotherapy
    Simin Xiang, Sen Li, Junfen Xu · 2025 · Clinical and Translational Medicine
64. Regulatory T Cells in Human Ovarian Cancer
    Dong-Jun Peng, Rebecca Liu, Weiping Zou · 2012 · Journal of Oncology
65. Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
    Sven Hans Petersen, Ley‐Fang Kua, Shotaro Nakajima, Wei Peng Yong, Koji Kono · 2021 · Scientific Reports
66. Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview
    Priyatharcini Kejamurthy, K. T. Ramya Devi · 2023 · Medical Oncology
67. Immune Therapy for Ovarian Cancer: Promise and Pitfalls
    Suzanne R. Thibodeaux, Tyler Jay Curiel · 2011 · International Reviews of Immunology
68. A prognostic index for colorectal cancer based on preoperative absolute lymphocyte, monocyte, and neutrophil counts
    Akimitsu Tanio, Hiroaki Saito, Chihiro Uejima, Seigo Takaya, Manabu Yamamoto, Naruo Tokuyasu, Teruhisa Sakamoto, Soichiro Honjo, Keigo Ashida, Yoshiyuki Fujiwara · 2018 · Surgery Today
69. Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance
    Tijana Martinov, Brian T. Fife · 2019 · Annals of the New York Academy of Sciences
70. Inhibitory costimulation and anti-tumor immunity
    Natalia Martín‐Orozco, Chen Dong · 2007 · Seminars in Cancer Biology
71. BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma
    Seung‐Tae Lee, Yun-Fang Jiang, Keon Uk Park, Alison F. Woo, Sattva Swarup Neelapu · 2006 · Expert Opinion on Biological Therapy
72. Anti-PD1 and Anti-PD-L1 in the Treatment of Metastatic Melanoma
    Ester Simeone, Antonio Maria Grimaldi, Paolo A. Ascierto · 2015 · Melanoma Management
73. The Immunotherapy Revolution in Kidney Cancer Treatment
    Elshad Hasanov, Jianjun Gao, Nizar M. Tannir · 2020 · The Cancer Journal
74. PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo
    Qibin Liao, Yunyu Mao, Huan He, Xiangqing Ding, Xiaoyan Zhang, Jianqing Xu · 2020 · Biomarker Research
75. Interaction of long non-coding RNAs and circular RNAs with microRNAs for the regulation of immunological responses in human cancers
    Ammad Ahmad Farooqı, Rükset Attar, Margarita Ishmuratova, Rossana Berardi · 2021 · Seminars in Cell and Developmental Biology
76. Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer
    Long Jiang, Ze-Rui Zhao, Shanshan Jiang, Yongbin Lin, Han Yang, Zehua Xie, Yaobin Lin, Hao Long · 2015 · Immunologic Research
77. Burn injury suppresses human dermal dendritic cell and Langerhans cell function
    Linda Berg, Marein A.W.P. de Jong, Lot D. de Witte, Magda M. W. Ulrich, Teunis B. H. Geijtenbeek · 2011 · Cellular Immunology
78. Strategies and challenges in eliciting immunity to melanoma
    Andrew R. Ferguson, Lisa A. Nichols, Angela L. Zarling, Elizabeth D. Thompson, C. Colin Brinkman, Kristian Michael Hargadon, Timothy N. J. Bullock, Víctor H. Engelhard · 2008 · Immunological Reviews
79. PD-1 Suppresses Development of Humoral Responses That Protect against Tn-Bearing Tumors
    Marcela Haro, Chad A. Littrell, Zhaojun Yin, Xuefei Huang, Karen M. Haas · 2016 · Cancer Immunology Research
80. Immunotherapeutic strategies employing RNA interference technology for the control of cancers
    Chih-Ping Mao, Chien‐Fu Hung, T.‐C. Wu · 2006 · Journal of Biomedical Science
81. Regulatory T Cells in Cancer
    Tyler Jay Curiel · 2011 · Springer eBooks
82. Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors
    Chih-Wei Chu, Tomislav Čaval, Frederico Alisson‐Silva, Akshaya Tankasala, Christina Guerrier, Gregg A. Czerwieniec, Heinz Philipp Laubli, Flavio Schwarz · 2024 · Life Science Alliance
83. PD-1 Expression on Circulating CD8+ T-Cells as a Prognostic Marker for Patients With Gastric Cancer
    Hiroaki Saito, Shota Shimizu, Yusuke Kono, Yuki Murakami, Yuji Shishido, Kozo Miyatani, Tomoyuki Matsunaga, Yoji Fukumoto, Keigo Ashida, Yoshiyuki Fujiwara · 2018 · Anticancer Research
84. Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
    Vallì De Re, Laura Caggiari, Ombretta Repetto, Lara Mussolin, Maurizio Mascarin · 2019 · Journal of Clinical Medicine
85. IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer
    Lina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, Gabriel M. Groisman, Ofer Limonad, Mordechai Hallak, Ilan Bruchim · 2020 · Translational Oncology
86. Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
    Likui Fang, Wuchen Zhao, Bo Ye, Da Chen · 2021 · Frontiers in Oncology
87. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
    Yao-Nan Li, Bin Xie, Ying Zhang, Ming-Hua He, Yang Xing, Dongmei Mu, Hong Wang, Rui Guo · 2023 · World Journal of Gastroenterology
88. PD ‐1 modulates steady‐state and infection‐induced IL ‐10 production in vivo
    Cortez McBerry, Alexandra Dias, Nathaniel Shryock, Kristin Lampe, Fredy R. S. Gutierrez, Louis Boon, De’Broski R. Herbert, Júlio Aliberti · 2013 · European Journal of Immunology
89. Anti-tumor immunity: Myeloid leukocytes control the immune landscape
    Melanie R. Rutkowski, Tom Li Stephen, Jose Ramon Conejo-Garcia · 2012 · Cellular Immunology
90. Melanoma immunotherapy dominates the field
    Panagiotis Theodorou Diamantopoulos, Helen J Gogas · 2016 · Annals of Translational Medicine
91. The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers
    Viriya Kaewkangsadan, Chandan Verma, Jennifer M. Eremin, Gerard Cowley, Mohammad Ilyas, Sukchai Satthaporn, Oleg Eremin · 2017 · Journal of Immunology Research
92. Dendritic Cell Vaccines
    Rachel Lubong Sabado, Marcia L. Meseck, Nina Bhardwaj · 2016 · Methods in molecular biology
93. Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells
    Suzanne Ostrand‐Rosenberg, Lucas A. Horn, Juan A. García Álvarez · 2015 · Cancer Immunology Immunotherapy
94. Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab
    Toshiki Iwai, Masamichi Sugimoto, Namrata S. Patil, Daniel Bower, Miho Suzuki, Chie Kato, Keigo Yorozu, Mitsue Kurasawa, David S. Shames, Osamu Kondoh · 2021 · Scientific Reports
95. The role of cellular proteostasis in antitumor immunity
    Rebecca Mercier, Paul LaPointe · 2022 · Journal of Biological Chemistry
96. Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
    Vijay Kumar, Caitlin Bauer, John H. Stewart · 2023 · Journal of Biomedical Science
97. CMTM6 as a master regulator of PD-L1
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani · 2022 · Cancer Immunology Immunotherapy
98. Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer
    Yuzhao Jin, Jin Fang Jiang, Wei Bo Mao, Minghua Bai, Qianping Chen, Ji Ye Zhu · 2024 · Cancer Letters
99. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer
    Keiichiro Kumamoto, Takashi Tasaki, Koji Ohnishi, Michihiko Shibata, Shohei Shimajiri, Masaru Harada, Yoshihiro Komohara, Toshiyuki Nakayama · 2021 · Frontiers in Oncology
100. PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
     Jelena D. Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, Daniel Ivanov, Gregor Eisenwort, Elisa Rumi, Michael K. Schuster, Bettina Gisslinger, Sigrid Machherndl‐Spandl, Peter Bettelheim et al. · 2022 · American Journal of Hematology